Editorial & Columns Foreign Direct Investment and Pharmaceutical Industry in India April 5, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Third Generation Curse : Caution & Survival Lessons for family-owned Pharmaceutical Companies in India March 14, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Private Equity and Indian Pharmaceutical Industry- A Review March 7, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Indian Pharmaceutical Industry’s dependence on China for APIs, KSMs & Intermediates: A Historical Perspective March 1, 2024 | Dr. Anil Kumar Angrish | No Comments | More